Product Code: VMR11211929
Value Market Research deeply researched the Global Microneedle Drug Delivery Systems Market to foresee a significant growth in the industry over the upcoming years. The global microneedle drug delivery systems market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global microneedle drug delivery systems market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this microneedle drug delivery systems market.
The next sections of the microneedle drug delivery systems market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
North America - United States, Canada, and Mexico
Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC
Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America
Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below-
By Product Type
Solid Microneedle Technology
Hollow Microneedle Technology
Dissolving Microneedle Technology
By Application
Drug Delivery
Vaccine Delivery
Other
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Microneedle Drug Delivery Systems Market
- 2.2. Global Microneedle Drug Delivery Systems Market Snapshot
3 . MICRONEEDLE DRUG DELIVERY SYSTEMS - INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers of Microneedle Drug Delivery Systems Market
- 3.3. Market Restraints of Microneedle Drug Delivery Systems Market
- 3.4. Opportunities of Microneedle Drug Delivery Systems Market
- 3.5. Trends of Microneedle Drug Delivery Systems Market
- 3.6. Porter's Five Force Analysis of Microneedle Drug Delivery Systems Market
- 3.7. Microneedle Drug Delivery Systems Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Product Type
- 3.7.2 Market Attractive Analysis by Application
- 3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Microneedle Drug Delivery Systems Value Chain Analysis
- 4.2. Microneedle Drug Delivery Systems Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Microneedle Drug Delivery Systems Raw Material Manufactures List
- 4.2.3. Price Trend of Microneedle Drug Delivery Systems Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 5.1. Impact Analysis of Covid-19 Outbreak on Microneedle Drug Delivery Systems Market
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
- 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 5.3. Microneedle Drug Delivery Systems Market: Pre V/S Post COVID-19
- 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Microneedle Drug Delivery Systems Market
- 5.5. COVID-19: Micro and Macro Factor Analysis on Microneedle Drug Delivery Systems Market
6 . GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY PRODUCT TYPE
- 6.1 Overview by Product Type
- 6.2 Historical Data 2016-2019
- 6.3 Global Microneedle Drug Delivery Systems Market Analysis by Product Type
- 6.4 Market Analysis of Solid Microneedle Technology by Regions
- 6.6 Market Analysis of Hollow Microneedle Technology by Regions
- 6.5 Market Analysis of Dissolving Microneedle Technology by Regions
7 . GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical Data 2016-2019
- 7.3 Global Microneedle Drug Delivery Systems Market Analysis by Application
- 7.4 Market Analysis of Drug Delivery by Regions
- 7.5 Market Analysis of Vaccine Delivery by Regions
- 7.6 Market Analysis of Other by Regions
8 . GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America
- 8.3.1. Overview and Historic Data
- 8.3.2. North America Microneedle Drug Delivery Systems Market Estimate By Market Segment
- 8.3.3. North America Microneedle Drug Delivery Systems Market Estimate By Country
- 8.3.4. United State
- 8.3.5. Canada
- 8.3.6. Mexico
- 8.4. Europe
- 8.4.1. Overview and Historic Data
- 8.4.2. Europe Microneedle Drug Delivery Systems Market Estimate by Market Segment
- 8.4.3. Europe Microneedle Drug Delivery Systems Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7. Italy
- 8.4.8. Russia
- 8.4.9. Rest Of Europe
- 8.5. Asia Pacific
- 8.5.1. Overview and Historic Data
- 8.5.2. Asia Pacific Microneedle Drug Delivery Systems Market Estimate by Market Segment
- 8.5.3. Asia Pacific Microneedle Drug Delivery Systems Market Estimate by Country
- 8.5.4. China
- 8.5.5. India
- 8.5.6. Japan
- 8.5.7. South Korea
- 8.5.8. Australia
- 8.5.9. Rest Of Asia Pacific
- 8.6. Latin America
- 8.6.1. Overview and Historic Data
- 8.6.2. Latin America Microneedle Drug Delivery Systems Market Estimate by Market Segment
- 8.6.3. Latin America Microneedle Drug Delivery Systems Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Argentina
- 8.6.6. Peru
- 8.6.7. Chile
- 8.6.8. Rest of Latin America
- 8.7. Middle East & Africa
- 8.7.1. Overview and Historic Data
- 8.7.2. Middle East & Africa Microneedle Drug Delivery Systems Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Microneedle Drug Delivery Systems Market Estimate by Country
- 8.7.4. Saudi Arabia
- 8.7.5. UAE
- 8.7.6. Israel
- 8.7.7. South Africa
- 8.7.8. Rest Of Middle East And Africa
9 . COMPETITIVE LANDSCAPE OF THE MICRONEEDLE DRUG DELIVERY SYSTEMS COMPANIES
- 9.1. Microneedle Drug Delivery Systems Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF MICRONEEDLE DRUG DELIVERY SYSTEMS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. 3M Company
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Becton-Dickinson BD Technologies
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Nanopass Technologies Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Corium Inc.
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Microdermics
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. TheraJect Inc.
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Johnson & Johnson
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Lohmann Therapie-Systeme AG
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Novartis
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Bayer
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies